Lombard Medical Priced, Nasdaq: EVAR
Offers innovative stent-grafts for highly angled endovascular aortic repair.
Industry: Health Care
First Day Return: -9.1%
EVAR
Offers innovative stent-grafts for highly angled endovascular aortic repair.
| IPO Data | |
|---|---|
| IPO Date | 04/24/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $55 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Oxfordshire, United Kingdom |
| Founded | 2003 |
| Employees at IPO | 121 |
| Website www.lombardmedical.com | |
IPO News for Lombard Medical
Lombard Medical (EVAR) Performance
